EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 · Journal of Hepatology · 495 citations
https://doi.org/10.1016/j.jhep.2024.08.028
M
Maxime Ronot
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
592
Papers
11.6K
Citations
55
h-index
254
i10-index
Maxime Ronot is an academic researcher from Inserm. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 55, co-authored 504 publications.
ORCID: 0000-0001-7464-3939Papers by this author
worksPredictive Factors of Intestinal Necrosis in Acute Mesenteric Ischemia: Prospective Study from an Intestinal Stroke Center
2017 · The American Journal of Gastroenterology · 233 citations
https://doi.org/10.1038/ajg.2017.38
Evaluation of liver tumour response by imaging
2020 · JHEP Reports · 61 citations
https://doi.org/10.1016/j.jhepr.2020.100100
Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
2021 · Scientific Reports · 59 citations
https://doi.org/10.1038/s41598-021-98012-w
Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
2019 · Cancer Imaging · 50 citations
https://doi.org/10.1186/s40644-019-0260-2
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
2021 · JHEP Reports · 46 citations
https://doi.org/10.1016/j.jhepr.2021.100390
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat